Ce diaporama a bien été signalé.
Le téléchargement de votre SlideShare est en cours. ×

G6PD-04.pptx

Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Prochain SlideShare
G6PD-02.pptx
G6PD-02.pptx
Chargement dans…3
×

Consultez-les par la suite

1 sur 4 Publicité

Plus De Contenu Connexe

Similaire à G6PD-04.pptx (20)

Plus récents (20)

Publicité

G6PD-04.pptx

  1. 1. G6PD
  2. 2. Antioxidant deficit and enhanced susceptibility to oxidative damage in individuals with different forms of a-thalassaemia Thalassaemia refers to a heterogeneous group of inherited anaemias characterized by defects in the synthesis of a- and b- globins (Schrier, 1994; Weatherall, 1998). The genetic defects of a-thalassaemias are commonly caused by deletion of one or more of the a-globin genes on chromosome 16. Depending on the number and position of the deletion(s), a-thalassaemias can be divided into several subtypes: a-thalassaemia trait, with two defective loci; haemoglobin H disease, with three dysfunctional loci; and the most severe form, fetal hydrops syndrome with Hb Barts, in which all four loci are defective (Schwartz & Benz, 1991). a-Thalassaemia with two a-globin gene deletions can be further divided into two major groups. One group has deletions of one a-globin gene from each chromosome (i.e. homozygosity or compound heterozygosity for a+ -thalassaemia deletions); whereas the other group has deletions of both a-globin genes from the same chromosome (i.e. ao -thalassaemia deletion). In Taiwan, the latter group commonly results from Southeast Asian (SEA) deletion (Ko et al, 1992). The clinical presentations of different a-thalass- aemic subtypes vary from mild to moderately severe haemo- lytic anaemia (Weatherall, 1999). Thalassaemia is rather common in the Taiwanese population. It has been estima- ted that around 6–8% of Taiwanese are carriers of the a-thalassaemic gene (Lin et al, 1991; Hsiao, 1992; Ko et al, 1992). The high incidence of this genetic disorder raises a concern about the health of affected individuals. Reactive oxygen species (ROS) are implicated in the pathogenesis of cancer, immune dysfunction and many degenerative diseases, such as cardiovascular diseases, cata- racts, and Alzheimer’s disease (Ruberg et al, 1998; Suematsu & Tsuchiya, 1998; Blankenberg et al, 2003; Brennan et al, 2003). There is an intimate relationship between oxidative stress and anaemia. ROS have been shown to damage and change membrane properties of erythrocytes. Increased membrane Mei-ling Cheng,1,2, * Hung-yao Ho,1, * Hsiu-chuan Tseng,1 Chien-Hong Lee,1,2 Lee-yung Shih3 and Daniel Tsun-yee Chiu1 1 Graduate Institute of Medical Biotechnology & Department of Medical Biotechnology and Laboratory Science, Chang Gung University, Kwei-san, Tao-yuan, Taiwan, 2 Molecular Diagnosis Laboratory, Department of Clinical Pathology, Chang Gung Memorial Hospital, Kwei-san, Tao-yuan, Taiwan, and 3 Department of Haematology & Oncology, Chang Gung Memorial Hospital, Kwei-san, Tao-yuan, Taiwan *These authors contributed equally to this paper. Received 12 August 2004; accepted for publication 4 October 2004 Correspondence: Dr Daniel Tsun-Yee Chiu, Professor, Graduate Institute of Medical Biotechnology and Department of Medical Biotechnology and Laboratory Science, Chang Gung University, 259 Wen-Hua 1st Road, Kwei-san, Tao-yuan, Taiwan. E-mail: dtychiu@mail.cgu.edu.tw Sum m ar y a-Thalassaemia is a common red cell disorder in Taiwan, affecting 6–8% of Taiwanese. Previous studies have shown that reactive oxygen species are generated in increased amounts in thalassaemic red cells. This implies the possible alteration of redox status in thalassaemic patients, which may adversely affect their health. In the present study, the redox status of patients with a-thalassaemia trait and haemoglobin H (Hb H) disease was investigated. Lipid peroxidation, as measured by the level of plasma thiobarbituric acid reactive substances (TBARS), was increased in a-thalassaemic patients, with the highest level of TBARS in Hb H disease patient. The plasma levels of vitamin A, C, and E were significantly lower in a-thalassaemic patients than in controls. The overall antioxidant capacity in plasma was inversely correlated with the severity of a-globin gene defect: the more severe the form of a-thalassaemia, the lower the overall antioxidant capacity in plasma. Erythrocytes isolated from a-thalassaemia patients had lower levels of vitamin E, glutathione, catalase and superoxide dismutase. In addition, these a-thalassaemic red cells were more susceptible to hydrogen peroxide-induced lipid peroxidation and decrease in deformability. All these data suggest that the a-thalassaemic patients suffer from increased oxidative stress and antioxidant deficit, which may complicate the pathophysiology of a-thalassaemia. Keywords: a-thalassaemia, lipid peroxidation, oxidative stress, reactive oxygen species, erythrocytes. research paper
  3. 3. rigidity, decreased deformability, and haemolysis are conse- quences of oxidative damage to erythrocytes (Lubin & Chiu, 1982; Snyder et al, 1985; Chiu et al, 1989; Cheng et al, 1999a). Moreover, oxidative insult may result in immune recognition and eventual removal of red blood cells from the circulation (Low et al, 1985). Several lines of evidence suggest that ROS are involved in the pathogenesis of thalassaemias. It has been shown that ROS are generated in increased amounts in thalassaemic erythrocytes because of the presence of excess unmatched globin chains, and deposition of iron, non-haem iron and haemichromes (Shinar & Rachmilewitz, 1990; Hebbel, 1991; Schrier & Mohandas, 1992; Anastassopoulou et al, 2000; Schrier, 2002). Continuous ROS production in thalassaemic individuals may alter their overall redox status and cause other health problems. This appears to be the case in b-thalassaemia. Reduction in the levels of vitamin C, vitamin E, and carotenoids has been reported in b-thalassaemic patients, especially in those receiv- ing transfusion therapy (Giardini et al, 1981, 1985; Miniero et al, 1982; Livrea et al, 1996, 1998; Tesoriere et al, 1998). Low- density lipoprotein (LDL) isolated from b-thalassaemic patients has high levels of oxidized lipid and protein compo- nents (Livrea et al, 1998), and is highly susceptible to oxidative modification (Tesoriere et al, 1998). The latter may account for the incidence of atherogenic vascular diseases often reported in b-thalassaemic patients (Butthep et al, 1995). On the other hand, very little is known about the effect of the a globin gene mutation on the redox balance of individuals with a-thalas- saemia. So far, no systematic study on redox status of a-thalassaemic patients has been conducted. In the present study, we demonstrate that a-thalassaemic individuals were deficient in plasma antioxidants, and suffered from higher levels of oxidative stress. The deficit of overall antioxidant capacity correlated with the severity of the form of a-thalassaemia. The a-thalassaemic erythrocytes, with crippled antioxidant defence, showed increased lipid peroxidation of their cell membrane. Moreover, these cells were more susceptible to oxidant-induced lipid peroxidation and decrease in deformability. Taken together, our experimental findings suggest that the redox status is altered in a-thalassaemic subjects, and this change may be implicated in the patho- physiology of a-thalassaemia, particularly, in the elderly thalassaemic individuals. Materials and methods Chemicals Unless otherwise stated, all chemicals were obtained from Sigma Chemical Company (St Louis, MO, USA). Patients A total of 182 a-thalassaemic individuals and 50 healthy volunteers were enrolled in the present study. Eighty-seven Determination of vitamin A, E, and C in plasma A method modified from that of Russel et al (1986) was used for determination of plasma vitamin A and vitamin E (Cheng et al, 1995). Briefly, 0Æ2 ml of d-tocopherol (1 lg/ml in absolute ethanol) was added to an equal volume of plasma while vortexing. After vortexing for 10 s, 1 ml of hexane was added. The mixture was centrifuged at 1000 g for 5 min, and the hexane layer was transferred to a vial for high performance liquid chromatography (HPLC) analysis using the Waters Alliance 2690 system (Waters, Milford, CA, USA). A lBondpark column was used. The mobile phase was methanol and H2O (95:5, v/v) and the flow rate was 1Æ6 ml/min. Vitamin A was detected by an ultraviolet detector at 325 nm. Vitamin E was detected using a fluorescence detector with excitation and emission at 290 and 330 nm, respectively.
  4. 4. Determination of vitamin A, E, and C in plasma A method modified from that of Russel et al (1986) was used for determination of plasma vitamin A and vitamin E (Cheng et al, 1995). Briefly, 0Æ2 ml of d-tocopherol (1 lg/ml in absolute ethanol) was added to an equal volume of plasma while vortexing. After vortexing for 10 s, 1 ml of hexane was added. The mixture was centrifuged at 1000 g for 5 min, and the hexane layer was transferred to a vial for high performance liquid chromatography (HPLC) analysis using the Waters Alliance 2690 system (Waters, Milford, CA, USA). A lBondpark column was used. The mobile phase was methanol and H2O (95:5, v/v) and the flow rate was 1Æ6 ml/min. Vitamin A was detected by an ultraviolet detector at 325 nm. Vitamin E was detected using a fluorescence detector with excitation and emission at 290 and 330 nm, respectively.

×